Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
Recent LLY News Headlines
Latest news coverage for LLY aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.
- Eli Lilly-backed TRex Bio closes day flat after IPO
- Eli Lilly-Backed Biotech TRex Dips 3.6% After $116.7 Million IPO
- Eli Lilly (LLY) As Zepbound And Retatrutide Updates Test Whether More Upside Is Priced In
- Combining Eli Lilly's Taltz with Zepbound could enhance psoriasis, metabolic benefits
- Eli Lilly (LLY) Posted 48% Revenue Growth. Why Does the Stock Trade Below Its Average Multiple?
- Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
- Eli Lilly: Weight-Loss Money Machine Isn't Slowing Down (NYSE:LLY)
- Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share (LLY:NYSE)
- Top Analyst Reports for Eli Lilly, Procter & Gamble & Shell
- Top Analyst Reports for Eli Lilly, Procter & Gamble & Shell
- Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform
- Transcript: Eli Lilly Q2 2026 Earnings Conference Call
- Eli Lilly, Glaukos among market cap stock movers on Thursday
- Eli Lilly (LLY) Has a Powerful Growth Flywheel Beyond Its GLP-1 Success
- Cantor Fitzgerald raises Eli Lilly stock price target on demand trends
LLY options: max pain, gamma exposure (GEX) & key levels · Search LLY in the news archive · All tickers
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]